Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting

    NEXT STORY
    ADMA Biologics Announces Pricing of Public Offering of Common Stock
    PREV STORY
    Terveystalo’s network of occupational health services to expand: Terveystalo to acquire Työsyke Oy in Kanta-Häme
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    TLC Appoints George Spencer-Green, MD, MS, as Chief Medical Officer

    TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Taiwan ...

    author_avatar
    NASDAQ Market News

    Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD

    LIVONIA, Mich., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a ...

    author_avatar
    NASDAQ Market News

    ADMA Biologics Reports Third Quarter 2020 Financial Results and Business Highlights

    author_avatar
    NASDAQ Market News